United States, 2015

Details for Healthcare Professionals

Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended adult (anyone over 18 years old) immunization schedule to ensure that the schedule reflects current recommendations for the licensed vaccines.

The recommended adult immunization schedule has been approved by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG), the American College of Physicians (ACP), and the American College of Nurse-Midwives (ACNM).

View or Print Schedules

Easy-to-read Version for Patients

Recommended Immunization for Adults (those 19 years and older)

You can display the easy-to-read schedules for patients on your website. See how the adult schedule by age and the adult schedule by medical condition will appear on your website. For instructions, see Display Immunization Schedules on Your Website.

Spanish version is not available.

Interactive Tools

The Interactive Adult Scheduler online tool is no longer available.

• Use your state or local immunization information system (IIS) to assess patient immunization status. For access, see Awardee Immunization Websites.
• Also see the Adult schedules (adult, adult medical and other indications, adult contraindications and precautions).
  • print and online versions
    • Adult schedule
    • By vaccine and age group
    • Medical indications
    • Contraindications and precautions
  • iOS or Android app version

Pocket-size

Laminated

• Order free copies from CDC (Available April 2015)
  (See note for instructions)
• Purchase laminated versions at IAC
  Immunization Action Coalition (IAC)

Spanish Version (en español)

The adult schedules are no longer available in Spanish.

Recommendations Published in MMWR

• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13) among adults aged ≥65 years. This report outlines the new recommendations for PCV13 use, provides guidance for use of PCV13 and PPSV23 among adults aged ≥65 years, and summarizes the evidence considered by ACIP to make this recommendation.
• Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–15 Influenza Season. MMWR 2014;63(32):691–697.

Changes in the Schedule Effective February 3, 2015

The Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended Adult Immunization Schedule to ensure that the schedule reflects current recommendations for the licensed vaccines. The primary changes include:

The 2015 adult immunization schedule contains the following changes from the 2014 schedule:

• Figure 1, the recommended adult immunization schedule by vaccine and age group, has been revised to designate PCV13 for adults aged 65 years or older as "recommended" (from the previous "recommended if some other risk is present"). Figure 2, showing vaccines that might be indicated for adults on the basis of medical and other indications, is unchanged.
• The footnotes for pneumococcal vaccination have been revised to provide algorithmic, patient-based guidance for the health care provider to arrive at appropriate vaccination decisions for individual patients.
• The footnote for influenza vaccination has been updated to indicate that adults aged 18 years or older (changed from adults aged 18 through 49 years) can receive RIV. A list of currently available influenza vaccines can be found at http://www.cdc.gov/flu/protect/vaccine/vaccines.htm.
• Table 1, showing contraindications and precautions to commonly used vaccines in adults, has been revised to update the section on LAIV to reflect the changes in the ACIP recommendations for the 2014–2015 influenza season. These changes include moving "influenza antiviral use within the last 48 hours" from the precautions column to the contraindications column, and moving asthma and chronic lung diseases; cardiovascular, renal, and hepatic diseases; and diabetes and other conditions from the contraindications column to the precautions column. Immune suppression, egg allergy, and pregnancy remain contraindications for LAIV.

Presentation Graphics

These slides are only snapshots of the chart and footnote portions of the immunization schedule and are provided for use in PowerPoint presentations:

PPT slides

• Slides of schedules[4.62 MB - 5 slides]

Immunization Recommendations

Note: To find the schedule in the CDC ordering system, do the following: Within the ‘programs’ box select ‘immunizations and vaccines (schedules and booklets)’ and click search button. At the bottom of each product is a ‘more information’ link you can click if you wish to see product before ordering.

Top of Page